Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
A patient with malignant carcinoid syndrome was treated with a long-acting somatostatin analogue. The cutaneous and systemic improvement our patient had while receiving this therapy is described.
Altman
A R
AR
Department of Dermatology, Baylor College of Medicine, Houston, Tex.
Tschen
J A
JA
Rice
L
L
D000328:Adult; D001706:Biopsy; D005260:Female; D005483:Flushing / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy
D015282:Octreotide